Tirzepatide 5 mg: understanding the first real treatment dose

Why 5 mg is the threshold that actually counts

Tirzepatide is a dual GIP and GLP-1 receptor agonist — it works on two gut-hormone pathways that regulate appetite and blood-sugar control. The 2.5 mg tirzepatide pen is genuinely not designed to produce significant weight change; its job is to let your digestive system adapt before the active work begins. That framing matters, because some people feel underwhelmed at the start and wonder if the treatment is working at all.

At 5 mg, the receptor activation reaches a level where most people start to notice a real reduction in appetite, meals feel satisfying sooner, cravings become easier to manage, and the mental background noise around food tends to quieten. This is why clinical guidance describes 5 mg as the first maintenance step rather than a continuation of the settling-in period. The full tirzepatide dosing schedule runs from 2.5 mg through to 15 mg, with 5 mg as the second rung, but for many people it is also the first point where their experience of the medicine changes noticeably.

The NHS medicines page on tirzepatide describes the escalation pathway clearly: doses increase roughly every four weeks depending on tolerability. Your prescriber decides the pace, not the calendar.

What a prescriber looks for before approving the step up

Moving to 5 mg is not a simple tick-box exercise. A responsible prescriber considers several things together: how the 2.5 mg period went, whether any side effects are still active, whether the timing makes sense for your circumstances, and whether anything in your health picture has changed since your last review.

At our pharmacy, every repeat order (including a dose increase) goes through a same-day clinical review by a named, GPhC-registered prescriber. Not software. Not a questionnaire read by an administrator. A real clinician applies their judgement to your notes. If evidence of how you've been getting on at 2.5 mg is unclear, they will ask before proceeding.

This is also the stage where the contraception point becomes relevant for women using oral contraceptives. Because tirzepatide slows gastric emptying, the pill may be absorbed less reliably in the weeks following a dose increase. UK guidance recommends adding a non-oral method (such as condoms) for four weeks after moving up. If that applies to you, it is worth flagging before the increase happens rather than after.

A useful overview of the broader Mounjaro treatment covers eligibility, how the medicine works and what to expect across the full journey.

Side effects at 5 mg: what to expect and what to watch for

The gastrointestinal side effects of tirzepatide (nausea, loose stools, constipation, indigestion) tend to peak after a dose increase. Moving to 5 mg can bring a brief flare of symptoms that had settled at 2.5 mg. This is normal, it is expected, and for most people it passes within a week or two as the body recalibrates.

Practically speaking, some people find it helpful to eat smaller portions at the first few meals after a new pen, and to stay well hydrated. The Patient Information Leaflet that comes with each pen gives specific guidance on managing symptoms; following it alongside your prescriber's advice is the right approach. Our FAQs also cover common questions about managing the early weeks.

There are symptoms that deserve prompt medical attention rather than patience. Severe, persistent stomach pain that reaches toward the back (particularly if accompanied by vomiting) should not be waited out. This can be a sign of pancreatitis, a known but uncommon side effect of GLP-1 medicines. The MHRA highlighted this in its Drug Safety Update guidance and advises patients to seek urgent medical help if it occurs. Suspected side effects can also be reported at the MHRA Yellow Card scheme.

Thinking about whether this dose is right for you

Some people stay at 5 mg for longer than the standard four-week window, either because their prescriber decides it, or because they are managing a side effect that needs more time to resolve before increasing further. That is a clinical call, not a setback. The goal is the dose that works well for you, not the highest available dose by the shortest possible route.

Others will feel ready to move toward 7.5 mg or beyond. The decision involves the same framework as the earlier stages of tirzepatide dose escalation: tolerability, overall health picture, clinical evidence of how treatment is progressing. If you are weighing up higher doses further down the line, understanding what each increase involves helps you have a more useful conversation with your prescriber when the time comes.

For context on what treatment typically costs through a private licensed route, the Mounjaro pricing page sets out what an all-inclusive private prescription covers. There are no hidden fees and no subscription at nume, every repeat is reviewed individually.

If you are thinking about starting treatment or are mid-way through a conversation with a prescriber about dose, our clinical team is available seven days a week. Orders placed before noon on a working day (so before the school run if that helps) are dispatched the same day once approved. Speak to our prescribers by starting your free consultation here.